Outer membrane permeability of Î²-lactamase inhibitors inPseudomonas aeruginosa (Q71866107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Outer membrane permeability of beta-lactamase inhibitors in Pseudomonas aeruginosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Outer membrane permeability of Î²-lactamase inhibitors inPseudomonas aeruginosa (English)

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

11 June 2024

main subject

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

S. Satake

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607408

11 June 2024

T. Nakae

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607408

11 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7607408

11 June 2024

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

15 June 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7607408

full work available at URL

11 June 2024

https://academic.oup.com/femsle/article-pdf/129/2-3/251/19094276/129-2-3-251.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607408

http://academic.oup.com/femsle/article-pdf/129/2-3/251/19094276/129-2-3-251.pdf

11 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

FEMS Microbiology Letters

11 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

251-254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein

21 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

11 June 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

Role of OmpD2 and chromosomal β-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa

11 June 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.

11 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

The outer membrane of Pseudomonas aeruginosa is a barrier against the penetration of disaccharides

11 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases

11 June 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin

11 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads

11 June 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor

11 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.

11 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1574-6968.1995.TB07588.X

11 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607408%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference